Literature DB >> 15080306

Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac sprue.

Neal S Goldstein1.   

Abstract

Seven patients (mean age, 37.6 years; 5 women) had several weeks of gluten sensitivity (GS)-like symptoms; 2 had flu-like symptom prodromes. The 7 cases had morphologically similar biopsy specimens; all tissue fragments had uniform injury--increased lymphoplasmacytic lamina propria inflammation, moderate to complete villous flattening, numerous crypt mitoses, and markedly increased villous intraepithelial lymphocytes (IELs). All patients were diagnosed with GS and prescribed a gluten-free diet; all returned 9 to 38 weeks later questioning their diagnosis because symptoms had resolved substantially or completely. Clinical improvement was unrelated to gluten abstinence or ingestion. Repeated endoscopy and colonoscopy performed 4.1 to 16 months later showed normal mucosa in all 7 patients. Diseases other than GS can cause marked villous flattening and increased villous IELs in adults. The cause of small bowel mucosal injury is unknown. A similar non-GS-associated clinicopathologic complex, assumed to be due to a protracted viral enteritis or slow regression of a virus-induced immune reaction, occurs in children. The temporal aspects of symptom improvement and mucosal restitution in these 7 patients are similar to "acute self-limited colitis." An overly exuberant immune response to an infectious agent is possible.

Entities:  

Mesh:

Year:  2004        PMID: 15080306     DOI: 10.1309/10FC-NCTC-56NM-N0YE

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

Review 1.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

2.  [20-year old woman with diarrhea of unknown etiology].

Authors:  M Wischmann; A B Buchwald
Journal:  Internist (Berl)       Date:  2006-03       Impact factor: 0.743

3.  Histologic evidence for mild lesions in coeliac disease: the challenge is open.

Authors:  Paola Ilaria Bianchi; Federico Biagi; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-05-15       Impact factor: 3.397

4.  Intake and sources of gluten in 20- to 75-year-old Danish adults: a national dietary survey.

Authors:  Camilla Hoppe; Rikke Gøbel; Mette Kristensen; Mads Vendelbo Lind; Jeppe Matthiessen; Tue Christensen; Ellen Trolle; Sisse Fagt; Mia Linda Madsen; Steffen Husby
Journal:  Eur J Nutr       Date:  2015-10-06       Impact factor: 5.614

5.  Comparison of non-invasive tests with invasive tests in the diagnosis of celiac disease.

Authors:  Yasemin Derya Gülseren; Ali Kudret Adiloğlu; Mihriban Yücel; Zuhal Dağ; Nilnur Eyerci; Rukiye Berkem; Levent Filik; Muzaffer Çaydere
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

6.  Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.

Authors:  T T Salmi; P Collin; I R Korponay-Szabó; K Laurila; J Partanen; H Huhtala; R Király; L Lorand; T Reunala; M Mäki; K Kaukinen
Journal:  Gut       Date:  2006-03-29       Impact factor: 23.059

7.  Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions.

Authors:  Anna Licata; Maria Cappello; Andrea Arini; Ada M Florena; Claudia Randazzo; Giuseppe Butera; Piero L Almasio; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2011-04-06       Impact factor: 3.397

Review 8.  Celiac disease in the elderly.

Authors:  Shadi Rashtak; Joseph A Murray
Journal:  Gastroenterol Clin North Am       Date:  2009-09       Impact factor: 3.806

Review 9.  Celiac Disease.

Authors:  Joshua Elliott Rubin; Sheila E Crowe
Journal:  Ann Intern Med       Date:  2020-01-07       Impact factor: 25.391

10.  Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.

Authors:  Jennifer A Nielsen; Anita Steephen; Matthew Lewin
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.